Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 41.90% institutional investors, 0.33% insiders, and 57.77% retail investors. Bvf inc/il is the largest institutional shareholder, holding 5.60% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.22% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eledon Pharmaceuticals	41.90%	0.33%	57.77%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	6.29M	5.60%	$24.80M
Vanguard group	4.04M	5.24%	$6.10M
Ra capital management	3.57M	4.62%	$9.24M
Blackrock funding, inc. /de	5.12M	4.56%	$20.19M
Vanguard capital management	3.42M	3.04%	$13.46M
Goldman sachs group	2.51M	2.23%	$9.89M
Ensign peak advisors	2.10M	1.87%	$8.28M
Geode capital management	1.96M	1.74%	$7.71M
Catalio capital management, lp	1.70M	1.51%	$6.68M
Jefferies financial group	1.09M	1.45%	$3.37M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
22nw, lp	636.36K	2.40%	$2.51M
Cm management	575.00K	1.44%	$2.27M
Catalio capital management, lp	1.70M	1.26%	$6.68M
Bvf inc/il	6.29M	0.63%	$24.80M
Sphera funds management	1.19M	0.61%	$4.69M
Kingdon capital management	1.04M	0.42%	$4.09M
Awm investment company	1.10M	0.38%	$4.33M
Exome asset management	114.14K	0.34%	$386.95K
Blue owl capital lp	566.51K	0.34%	$2.23M
Triumph capital management	303.44K	0.22%	$1.20M

Top Buyers

Holder	Shares	% Assets	Change
Goldman sachs group	2.51M	0.00%	2.14M
Millennium management	979.71K	0.00%	979.71K
Vanguard group	4.04M	0.00%	771.90K
Blackrock funding, inc. /de	5.12M	0.00%	741.60K
Kovitz investment group partners	732.98K	0.01%	732.98K

Top Sellers

Holder	Shares	% Assets	Change
First light asset management	-	-	-2.60M
Armistice capital	-	-	-2.36M
Siren	-	-	-2.07M
Frazier life sciences management	-	-	-1.18M
Nantahala capital management	-	-	-1.14M

New Positions

Holder	Shares	% Assets	Change	Value
Kovitz investment group partners	732.98K	0.01%	732.98K	$1.90M
Triumph capital management	303.44K	0.22%	303.44K	$1.20M
Sixth street partners management company	247.40K	0.00%	247.40K	$974.77K
Citadel advisors	215.97K	0.00%	215.97K	$850.93K
Inspire investing	194.69K	0.09%	194.69K	$802.12K

Sold Out

Holder	Change
Ifs advisors	-100.00
Root financial partners	-110.00
Mai capital management	-133.00
Ameritas advisory services	-1.00K
Addison advisors	-1.30K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	165	34.15%	47,104,068	10.52%	41	2.92%	110	41.03%	23	9.52%
Mar 31, 2026	73	-24.74%	16,252,212	-63.19%	21	0.66%	47	-25.40%	9	-50.00%
Dec 31, 2025	55	-36.78%	23,315,065	-36.07%	30	1.35%	33	-28.26%	11	-45.00%
Sep 30, 2025	87	6.10%	36,469,788	-9.28%	47	1.74%	46	-	20	42.86%
Jun 30, 2025	88	2.33%	40,843,213	6.23%	52	2.13%	48	37.14%	16	-23.81%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.48M	3.22%	127.10K
Vanguard Morn Total Stk Mkt Idx Investor	2.48M	3.22%	127.10K
Vanguard MStar Total Stk Mkt Idx Invest	2.48M	3.07%	-
iShares Russell 2000 ETF	1.99M	2.58%	-35.42K
Vanguard US Total Market Shares ETF	1.15M	1.92%	-
Vanguard Institutional Extnd Mkt Idx Tr	854.63K	1.06%	-
Fidelity Small Cap Index	752.78K	0.98%	12.75K
iShares Russell 2000 Growth ETF	705.85K	0.91%	-6.47K
iShares Russell 2000 Value ETF	597.63K	0.77%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	497.55K	0.64%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$440.49
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.10K
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.21K
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$1.95M
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$232.07

Insider Transactions Trends

Date	Buy	Sell
2035 Q1	-	-
2025 Q1	-	-
2024 Q4	3	-
2024 Q2	6	-
2023 Q4	-	-

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 41.90%, followed by 0.33% insiders and 57.77% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 379.61%, which Eledon Pharmaceuticals falls below.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 5.60%), Vanguard group (4.04M shares, 5.24%), and Ra capital management (3.57M shares, 4.62%). Together, they hold 15.46% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

22nw, lp is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.40% of its assets in 636.36K Eledon Pharmaceuticals shares, valued at 2.51M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.22% of its total shares outstanding invested in 2.48M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools